| INTRODUCTION
Prostate cancer (PC) is the most common malignancy among male worldwide and one of the principal causes of cancer death in the male population. 1 The early diagnosis can lead to more effective therapeutic intervention for patients. Prostate specific antigen (PSA) is a 33-kD glycoprotein secreted by the luminal cells of the prostate epithelium, and is the member of the kallikrein-related peptidase family of serine proteases. 2 PSA is widely used to screen for PC. 3, 4 It has been demonstrated to play an important role in PC pathobiology. 5 Previous studies have suggested that PSA was an independent risk factor in PC growth, invasion and metastasis. PSA is prostate specific but not PC specific. It is expressed not only in patients with PC but also in normal male and patients with prostatitis, urinary retention or benign prostate hyperplasia. 6, 7 Most of the total circulating PSA (tPSA) is bound as complex PSA, and small part of the circulating PSA is free PSA (fPSA).
Many studies indicated that the ratio of free to total PSA (%fPSA) was independently associated with PC. 8 Similarly to rising PSA, a lower %fPSA lead to a continuous risk for PC. Combination tPSA with fPSA and %fPSA can improve the accuracy and specificity for PC detection compared to tPSA alone. The reference intervals (RIs) in healthy population are very important for clinical diagnosis and treatment. The lack of appropriate weight. 1 Many studies illustrated that age had important impact on the diagnostic accuracy of PSA. Taking age into consideration when using PSA can reduce unnecessary biopsies. Lim et al. 6 demonstrated age and ethnicity were significant variables associated with PSA level.
Therefore, it is important to establish the age and race specific RIs for tPSA, fPSA and %fPSA.
In this study, we simultaneously measured the serum levels of tPSA and fPSA for healthy Han ethnic male with electrochemiluminescence assay (ECLIA) on Roche Cobas E601 system, and established the agespecific RIs for tPSA, fPSA and %fPSA in the healthy Han ethnic male according to the recommendations of the CLSI C28-A3 document.
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| MATERIALS AND METHODS
| Subjects
This study was approved by the ethics committee of the First Affiliated
Hospital of Zhengzhou University. We recruited 3000 China Han ethnic male from Henan Province, covering cities and villages. All of them signed the information consents, filled in the questionnaires and participated in physical examination. Individuals with prostatitis, urinary retention, prostate hyperplasia or prostate cancer were excluded.
Finally, 1862 apparently healthy male (aged from 21 to 94 years) were included in our study.
| Laboratory methods
All of the individuals participated in our study were required to keep their normal lifestyle and avoid massage of prostate, digital rectal examination, taking androgen antagonists, catheterization and cystoscopy for 2 weeks before the sample collection. They were also required to avoid ejaculation or strenuous exercise 2 days before the sample collection. Samples were collected into gel separator tubes (BD Bioscience, NJ, USA) and left for at least 30 minutes to clot at room temperature, then centrifuged for 10 minutes at 1200 g. Serum were collected in eppendorf tubes, and stored at −80°C until assayed.
The tPSA and fPSA levels were quantitatively measured by ECLIA on a Roche Cobas E601 system (Roche Diagnostics GmbH, Mannheim, Germany). The measuring ranges for tPSA and fPSA were 0.003-100 and 0.01-50 ng/mL, respectively. tPSA detection kit, fPSA detection kit, calibrators (total PSA CalSetII and free PSA CalSet), and controls (Elecsys PreciControl Tumor Marker 1 and 2) were provided by Roche Diagnostic GmbH. The total PSA assay can be traced to the Stanford Reference Standard/WHO 96/670 (90% PSA-ACT + 10% free PSA).
The free PSA assay has been standardized against the WHO Reference Standard 96/668 (100% free PSA).
All of the tests were performed according to standard operating procedures. The precision and accuracy were evaluated according to the document EP15A recommended by CLSI. 11 The total coefficient of variation (CV) was used to evaluate the precision, and the percent bias between the mean of the test results and the target value was used to evaluate the accuracy. The estimated total CV and the percent bias for tPSA and fPSA were all less than 1/2CLIA'88. 
| Statistical analysis
| RESULTS
The results of normality test (Kolmogorov-Smirnov test) showed tPSA, fPSA and %fPSA were all not in normal distribution (P<.05). According to CLSI C28-A3, we calculated the RIs for tPSA, fPSA, and %fPSA with nonparametric method. For tPSA and fPSA, only the upper reference limit is important. The upper reference limit was set at the 95th percentile value. While for %fPSA, only the lower reference limit is important. The corresponding lower reference limit was set at the 5th percentile value. The 90% confidence intervals of the reference limits were also calculated.
The percentile distribution for tPSA, fPSA, and %fPSA were shown in the Table 1 . Table 2 showed the RIs and 90% confidence intervals of the reference limits for tPSA, fPSA, and %fPSA. The RIs for the healthy Han ethnic male were ≤3.84 ng/mL for tPSA, ≤0.80 ng/mL for fPSA and ≥0.14 for %fPSA.
The percentile distribution of tPSA (ng/mL), fPSA (ng/mL), and %fPSA in reference individuals Table 4 . %fPSA was significantly decreased in patients with PC, while it was significantly increased in benign prostatic hyperplasia patients. The determination of %fPSA together with serum tPSA may help to differentiate more clearly between benign prostatic hyperplasia and PC.
| DISCUSSION
Combination of tPSA with fPSA and %fPSA can enhance the accuracy and specificity for PC detection compared to tPSA alone. Therefore, it is a prerequisite to define reliable RIs for tPSA, fPSA, and %fPSA.
T A B L E 2 The reference intervals and 90% confidence intervals for tPSA (ng/mL), fPSA (ng/mL), and %fPSA in reference individuals T A B L E 3 The percentile distribution of tPSA (ng/mL), fPSA (ng/mL), and %fPSA indifferent age groups
In this study, we used nonparametric statistical method to calculated RIs with 1-sided upper 95th percentiles for tPSA and fPSA, and 1-sided lower 5th percentile for %fPSA. We established the RIs for tPSA, fPSA, and %fPSA in healthy Han ethnic male with ECLIA according to the CLSI C28-A3 document. The RIs for tPSA, fPSA, and %fPSA were ≤3.84 ng/mL for tPSA, ≤0.80 ng/mL for fPSA and ≥0.14 for %fPSA. The tPSA threshold in our study was slightly lower than the international standard threshold 4.0 ng/mL. The international standard threshold was studied many decades ago, and both the methods and the population were different. Therefore, the standard threshold might be not applicable for Han ethnic male. Our result of tPSA was also lower than the Marwan's result in 2011. 17 This may be due to racial and geographical differences.
As we all know, carcinogenesis and subsequent cancer growth are related to a series of events at the molecular, cellular and physiological levels which are influenced by age. Our study showed that the levels of tPSA and fPSA increased with increasing age, while %PSA decreased with the increasing age. These were in parallel with previous studies. The limitations of our study were the lack of multicenter and multiethnic study for serum tPSA, fPSA and %fPSA levels. China is a multiethnic country. There are 56 ethnic groups. Other minorities account for 8.41% population of the whole country. In this study, we only researched the RIs of serum PSA in Han ethnic. Multiethnic RIs for serum tPSA, fPSA, and %fPSA should be more representative. Further studies on multicenter and multiethnic reference intervals for serum tPSA, fPSA, and %fPSA are particularly important in our future work.
In conclusion, we established the age-specific RIs for serum tPSA, fPSA, and % fPSA with ECLIA in healthy Han ethnic male according to the CLSI C28-A3 document. It provided a reference for physicians to make exact medical decision and appropriate medical intervention. T A B L E 4 Age-specific reference intervals and 90% confidence intervals for tPSA (ng/mL), fPSA (ng/mL), and %fPSA indifferent age groups 
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